Cargando…
Prostate Cancer Liquid Biopsy Biomarkers’ Clinical Utility in Diagnosis and Prognosis
SIMPLE SUMMARY: In prostate cancer, overdiagnosis and overtreatment is a common problem for clinicians. Accurate diagnosis and prognosis are essential to avoid unnecessary biopsy and to increases the effectiveness of treatment. A new, easy-to-use and non-invasive test based on liquid biopsy biomarke...
Autores principales: | Matuszczak, Milena, Schalken, Jack A., Salagierski, Maciej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268859/ https://www.ncbi.nlm.nih.gov/pubmed/34282798 http://dx.doi.org/10.3390/cancers13133373 |
Ejemplares similares
-
A Liquid Biopsy in Bladder Cancer—The Current Landscape in Urinary Biomarkers
por: Matuszczak, Milena, et al.
Publicado: (2022) -
PCA3 and TMPRSS2-ERG: Promising Biomarkers in Prostate Cancer Diagnosis
por: Salagierski, Maciej, et al.
Publicado: (2010) -
How accurate is our prediction of biopsy outcome? PCA3-based nomograms in personalized diagnosis of prostate cancer
por: Salagierski, Maciej, et al.
Publicado: (2012) -
Diagnostic and Prognostic Potential of Biomarkers CYFRA 21.1, ERCC1, p53, FGFR3 and TATI in Bladder Cancers
por: Matuszczak, Milena, et al.
Publicado: (2020) -
The Role of Focal Therapy and Active Surveillance for Small Renal Mass Therapy
por: Matuszczak, Milena, et al.
Publicado: (2022)